Moderna sues Pfizer & BioNTech over patent infringement of Covid-19 vaccine.
www.BeGenomics.com
SOURCE: Moderna, Inc.
BeGenomics.com
Moderna said it is suing Pfizer and its partner BioNTech for patent infringement in the development of the first Covid-19 vaccine.
www.BeGenomics.com
BeGenomics.com
They alleging that mRNA technology it developed before the pandemic was copied.
www.BeGenomics.com
BeGenomics.com
In a statement, Moderna said Pfizer/BioNTech copied two types of its intellectual property.
www.BeGenomics.com
BeGenomics.com
One involved an mRNA structure that Moderna says its scientists began developing in 2010 and were the first to validate in human trials in 2015.
www.BeGenomics.com
BeGenomics.com
The second alleged infringement involves the coding of the spike protein on the outside of the virus itself.
www.BeGenomics.com
BeGenomics.com
This groundbreaking technology was critical to the development of Moderna's own mRNA COVID-19 vaccine, Spikevax®.
www.BeGenomics.com
BeGenomics.com
Pfizer and BioNTech copied this technology, without Moderna's permission, to make Comirnaty®.
www.BeGenomics.com
BeGenomics.com
We believe that Pfizer and BioNTech unlawfully copied Moderna's inventions, and they have continued to use them without permission," said Moderna Chief Legal Officer
www.BeGenomics.com
BeGenomics.com
Moderna and Pfizer’s two-shot vaccines both use mRNA technology to help patients fight the coronavirus.